Cadence Pharmaceuticals™

Press Releases

  
All Releases
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
Jun 17, 2008 		PDF 10.2 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
Jun 4, 2008 		PDF 10.3 KB
View Summary Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
May 6, 2008 		PDF 20.7 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
Apr 30, 2008 		PDF 10.5 KB
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008
Apr 30, 2008 		PDF 10.6 KB
View Summary Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Mar 13, 2008 		PDF 10.3 KB
View Summary Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
Mar 12, 2008 		PDF 20.9 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
Mar 6, 2008 		PDF 10.5 KB
View Summary Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
Feb 20, 2008 		PDF 12.1 KB
View Summary Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Feb 15, 2008 		PDF 10.0 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
Jan 31, 2008 		PDF 10.2 KB
View Summary Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
Jan 11, 2008 		PDF 17.4 KB
View Summary Cadence Pharmaceuticals Reports Third Quarter 2007 Financial Results and Provides Clinical Program Update
Nov 14, 2007 		PDF 21.2 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
Nov 9, 2007 		PDF 10.4 KB
View Summary Cadence Pharmaceuticals' Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
Nov 8, 2007 		PDF 10.2 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
Oct 26, 2007 		PDF 10.2 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIO Investor Forum
Oct 3, 2007 		PDF 10.2 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
Sep 20, 2007 		PDF 10.2 KB
View Summary Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
Sep 13, 2007 		PDF 12.6 KB
View Summary Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
Aug 30, 2007 		PDF 15.2 KB
Showing 1-20 of 58 releases Page: 1 2 3  See Next 20
Print page Print
Email page Email


Stock Quote
CADX - (NASD)
$6.66   + 0.08
Jul 3, 2008
1:00 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by TurboFeed.

©2005 Cadence™ Pharmaceuticals. All rights reserved. No portion of cadencepharm.com may be duplicated, redistributed or manipulated in any form. CADENCE and OMIGARD are trademarks of Cadence Pharmaceuticals, Inc.